Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Jan 15;281(Pt 2):465–472. doi: 10.1042/bj2810465

Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion.

C P Wheeler-Jones 1, T Saermark 1, V V Kakkar 1, K S Authi 1
PMCID: PMC1130708  PMID: 1310599

Abstract

Recent studies have shown that mastoparan, an amphiphilic peptide derived from wasp venom, accelerates guanine nucleotide exchange and GTPase activity of purified GTP-binding proteins. In the present study we have examined the functional consequences of exposure of intact human platelets to mastoparan. Mastoparan promoted rapid (less than or equal to 1 min) dose-dependent increases in 5-hydroxy[14C]tryptamine and beta-thromboglobulin release from dense-granule and alpha-granule populations respectively. The exocytotic response did not result from a lytic effect of mastoparan and occurred in the complete absence of platelet shape change and aggregation. Liberation of [3H]arachidonate and increases in cytosolic [Ca2+] (detected with fura 2) were not observed in platelets stimulated with mastoparan. Similarly, in platelets preloaded with [3H]inositol during reversible electroporation, mastoparan did not cause the accumulation of [3H]inositol phosphates. Mastoparan-induced secretion was unaffected by preincubation with either the protein kinase C inhibitor staurosporine (10 nM-10 microM) or prostacyclin (PGI2; 100 ng/ml) and was not accompanied by phosphorylation of the 45 kDa protein kinase C substrate or the 20 kDa protein normally associated with platelet activation. The G-protein inhibitor guanosine 5'-[beta-thio]diphosphate (GDP[S]; 1 mM) attenuated the secretion induced by mastoparan in both intact and saponin-permeabilized platelets. Encapsulation of GDP[S] during reversible permeabilization inhibited mastoparan-induced secretion, providing evidence for an intracellular action of GDP[S]. In all these studies thrombin (0.05-0.2 unit/ml) elicited characteristic responses, and thrombin-induced secretion was inhibited by staurosporine, PGI2 and GDP[S]. Mastoparan also increased intra-platelet cyclic AMP in a dose-dependent manner. Mastoparan and PGI2 increased 32P incorporation into a protein of approx. 24 kDa, whereas phosphorylation of a 50 kDa substrate was only seen in PGI2-stimulated platelets. These results indicate that mastoparan promotes secretion by a mechanism which does not involve stimulation of phospholipase C and suggest that the secretory event may result either from a direct fusogenic action of mastoparan and/or from stimulation of the putative exocytosis-linked G-protein, Ge.

Full text

PDF
465

Images in this article

470Fig. 4.
on p.470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aktories K., Jakobs K. H. Ni-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem. 1984 Dec 3;145(2):333–338. doi: 10.1111/j.1432-1033.1984.tb08558.x. [DOI] [PubMed] [Google Scholar]
  2. Argiolas A., Pisano J. J. Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem. 1983 Nov 25;258(22):13697–13702. [PubMed] [Google Scholar]
  3. Aridor M., Traub L. M., Sagi-Eisenberg R. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J Cell Biol. 1990 Sep;111(3):909–917. doi: 10.1083/jcb.111.3.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Athayde C. M., Scrutton M. C. Guanine nucleotides and Ca2(+)-dependent lysosomal secretion in electropermeabilised human platelets. Eur J Biochem. 1990 May 20;189(3):647–655. doi: 10.1111/j.1432-1033.1990.tb15533.x. [DOI] [PubMed] [Google Scholar]
  5. Authi K. S., Evenden B. J., Crawford N. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets. Biochem J. 1986 Feb 1;233(3):707–718. doi: 10.1042/bj2330707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Authi K. S., Hughes K., Crawford N. High incorporation of [3H]inositol into phosphoinositides of human platelets during reversible electropermeabilisation. FEBS Lett. 1989 Aug 28;254(1-2):52–58. doi: 10.1016/0014-5793(89)81008-7. [DOI] [PubMed] [Google Scholar]
  7. Authi K. S., Rao G. H., Evenden B. J., Crawford N. Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J. 1988 Nov 1;255(3):885–893. doi: 10.1042/bj2550885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Barnette M. S., Daly R., Weiss B. Inhibition of calmodulin activity by insect venom peptides. Biochem Pharmacol. 1983 Oct 1;32(19):2929–2933. doi: 10.1016/0006-2952(83)90398-2. [DOI] [PubMed] [Google Scholar]
  9. Barrowman M. M., Cockcroft S., Gomperts B. D. Two roles for guanine nucleotides in the stimulus-secretion sequence of neutrophils. Nature. 1986 Feb 6;319(6053):504–507. doi: 10.1038/319504a0. [DOI] [PubMed] [Google Scholar]
  10. Chambard J. C., Pouyssegur J. Thrombin-induced protein phosphorylation in resting platelets and fibroblasts: evidence for common post-receptor molecular events. Biochem Biophys Res Commun. 1983 Mar 29;111(3):1034–1044. doi: 10.1016/0006-291x(83)91404-3. [DOI] [PubMed] [Google Scholar]
  11. Cockcroft S., Howell T. W., Gomperts B. D. Two G-proteins act in series to control stimulus-secretion coupling in mast cells: use of neomycin to distinguish between G-proteins controlling polyphosphoinositide phosphodiesterase and exocytosis. J Cell Biol. 1987 Dec;105(6 Pt 1):2745–2750. doi: 10.1083/jcb.105.6.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coorssen J. R., Davidson M. M., Haslam R. J. Factors affecting dense and alpha-granule secretion from electropermeabilized human platelets: Ca(2+)-independent actions of phorbol ester and GTP gamma S. Cell Regul. 1990 Dec;1(13):1027–1041. doi: 10.1091/mbc.1.13.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cutler L., Rodan G., Feinstein M. B. Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets. Biochim Biophys Acta. 1978 Sep 6;542(3):357–371. doi: 10.1016/0304-4165(78)90367-7. [DOI] [PubMed] [Google Scholar]
  14. Downes C. P., Wusteman M. M. Breakdown of polyphosphoinositides and not phosphatidylinositol accounts for muscarinic agonist-stimulated inositol phospholipid metabolism in rat parotid glands. Biochem J. 1983 Dec 15;216(3):633–640. doi: 10.1042/bj2160633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  17. Higashijima T., Burnier J., Ross E. M. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem. 1990 Aug 25;265(24):14176–14186. [PubMed] [Google Scholar]
  18. Higashijima T., Uzu S., Nakajima T., Ross E. M. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem. 1988 May 15;263(14):6491–6494. [PubMed] [Google Scholar]
  19. Hirai Y., Yasuhara T., Yoshida H., Nakajima T., Fujino M., Kitada C. A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Chem Pharm Bull (Tokyo) 1979 Aug;27(8):1942–1944. doi: 10.1248/cpb.27.1942. [DOI] [PubMed] [Google Scholar]
  20. Huang R., Kucera G. L., Rittenhouse S. E. Elevated cytosolic Ca2+ activates phospholipase D in human platelets. J Biol Chem. 1991 Jan 25;266(3):1652–1655. [PubMed] [Google Scholar]
  21. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 1987 Jan 30;142(2):436–440. doi: 10.1016/0006-291x(87)90293-2. [DOI] [PubMed] [Google Scholar]
  22. Krishnamurthi S., Joseph S. Arachidonate release in neutrophils: does a lack of effect of protein kinase C inhibitors imply no involvement of protein kinase C? Biochem J. 1989 Jul 15;261(2):687–688. doi: 10.1042/bj2610687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Krishnamurthi S., Joseph S., Kakkar V. V. 1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type. Eur J Biochem. 1987 Sep 15;167(3):585–593. doi: 10.1111/j.1432-1033.1987.tb13376.x. [DOI] [PubMed] [Google Scholar]
  24. Krishnamurthi S., Joseph S., Kakkar V. V. Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate. Biochem J. 1986 Aug 15;238(1):193–199. doi: 10.1042/bj2380193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Krishnamurthi S., Wheeler-Jones C. P., Kakkar V. V. Effect of phorbol ester treatment on receptor-mediated versus G-protein-activator-mediated responses in platelets. Evidence for a two-site action of phorbol ester at the level of G-protein function. Biochem J. 1989 Aug 15;262(1):77–81. doi: 10.1042/bj2620077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kurihara H., Kitajima K., Senda T., Fujita H., Nakajima T. Multigranular exocytosis induced by phospholipase A2-activators, melittin and mastoparan, in rat anterior pituitary cells. Cell Tissue Res. 1986;243(2):311–316. doi: 10.1007/BF00251045. [DOI] [PubMed] [Google Scholar]
  27. Lapetina E. G., Silió J., Ruggiero M. Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin. J Biol Chem. 1985 Jun 10;260(11):7078–7083. [PubMed] [Google Scholar]
  28. Moscat G., Moreno F., Iglesias S., Garcia-Barreno P., Municio A. M. Ionophore A23187 induces a refractory state in thrombin-activated release of inositol phosphates. Biochem J. 1986 Sep 15;238(3):709–714. doi: 10.1042/bj2380709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mousli M., Bronner C., Bueb J. L., Tschirhart E., Gies J. P., Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther. 1989 Jul;250(1):329–335. [PubMed] [Google Scholar]
  30. Mousli M., Bueb J. L., Bronner C., Rouot B., Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci. 1990 Sep;11(9):358–362. doi: 10.1016/0165-6147(90)90179-c. [DOI] [PubMed] [Google Scholar]
  31. Nakahata N., Abe M. T., Matsuoka I., Nakanishi H. Mastoparan inhibits phosphoinositide hydrolysis via pertussis toxin-insensitive [corrected] G-protein in human astrocytoma cells. FEBS Lett. 1990 Jan 15;260(1):91–94. doi: 10.1016/0014-5793(90)80074-s. [DOI] [PubMed] [Google Scholar]
  32. Ozaki Y., Matsumoto Y., Yatomi Y., Higashihara M., Kariya T., Kume S. Mastoparan, a wasp venom, activates platelets via pertussis toxin-sensitive GTP-binding proteins. Biochem Biophys Res Commun. 1990 Jul 31;170(2):779–785. doi: 10.1016/0006-291x(90)92159-w. [DOI] [PubMed] [Google Scholar]
  33. Ruggiero M., Zimmerman T. P., Lapetina E. G. ATP depletion in human platelets caused by permeabilization with saponin does not prevent serotonin secretion induced by collagen. Biochem Biophys Res Commun. 1985 Sep 16;131(2):620–627. doi: 10.1016/0006-291x(85)91282-3. [DOI] [PubMed] [Google Scholar]
  34. Sage S. O., Merritt J. E., Hallam T. J., Rink T. J. Receptor-mediated calcium entry in fura-2-loaded human platelets stimulated with ADP and thrombin. Dual-wavelengths studies with Mn2+. Biochem J. 1989 Mar 15;258(3):923–926. doi: 10.1042/bj2580923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Secrist J. P., Sehgal I., Powis G., Abraham R. T. Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine. J Biol Chem. 1990 Nov 25;265(33):20394–20400. [PubMed] [Google Scholar]
  36. Siess W., Lapetina E. G. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Biochem J. 1990 Nov 1;271(3):815–819. doi: 10.1042/bj2710815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989 Jan;69(1):58–178. doi: 10.1152/physrev.1989.69.1.58. [DOI] [PubMed] [Google Scholar]
  38. Siess W., Winegar D. A., Lapetina E. G. Rap1-B is phosphorylated by protein kinase A in intact human platelets. Biochem Biophys Res Commun. 1990 Jul 31;170(2):944–950. doi: 10.1016/0006-291x(90)92182-y. [DOI] [PubMed] [Google Scholar]
  39. Sontag J. M., Thierse D., Rouot B., Aunis D., Bader M. F. A pertussis-toxin-sensitive protein controls exocytosis in chromaffin cells at a step distal to the generation of second messengers. Biochem J. 1991 Mar 1;274(Pt 2):339–347. doi: 10.1042/bj2740339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tohkin M., Yagami T., Matsubara T. Mastoparan, a peptide toxin from wasp venom, stimulates glycogenolysis mediated by an increase of the cytosolic free Ca2+ concentration but not by an increase of cAMP in rat hepatocytes. FEBS Lett. 1990 Jan 29;260(2):179–182. doi: 10.1016/0014-5793(90)80098-4. [DOI] [PubMed] [Google Scholar]
  41. Van der Meulen J., Haslam R. J. Phorbol ester treatment of intact rabbit platelets greatly enhances both the basal and guanosine 5'-[gamma-thio]triphosphate-stimulated phospholipase D activities of isolated platelet membranes. Physiological activation of phospholipase D may be secondary to activation of phospholipase C. Biochem J. 1990 Nov 1;271(3):693–700. doi: 10.1042/bj2710693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wardell M. R., Reynolds C. C., Berndt M. C., Wallace R. W., Fox J. E. Platelet glycoprotein Ib beta is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J Biol Chem. 1989 Sep 15;264(26):15656–15661. [PubMed] [Google Scholar]
  43. Watson S. P., McNally J., Shipman L. J., Godfrey P. P. The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin. Biochem J. 1988 Jan 15;249(2):345–350. doi: 10.1042/bj2490345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wilson S. P. Effects of mastoparan on catecholamine release from chromaffin cells. FEBS Lett. 1989 Apr 24;247(2):239–241. doi: 10.1016/0014-5793(89)81343-2. [DOI] [PubMed] [Google Scholar]
  45. Wojcikiewicz R. J., Nahorski S. R. Phosphoinositide hydrolysis in permeabilized SH-SY5Y human neuroblastoma cells is inhibited by mastoparan. FEBS Lett. 1989 Apr 24;247(2):341–344. doi: 10.1016/0014-5793(89)81366-3. [DOI] [PubMed] [Google Scholar]
  46. Yokokawa N., Komatsu M., Takeda T., Aizawa T., Yamada T. Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein. Biochem Biophys Res Commun. 1989 Feb 15;158(3):712–716. doi: 10.1016/0006-291x(89)92779-4. [DOI] [PubMed] [Google Scholar]
  47. Zamorski M. A., Ferraro J. C., Neubig R. R. Subcellular distribution of alpha 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets. Biochem J. 1990 Feb 1;265(3):755–762. doi: 10.1042/bj2650755. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES